Go to main content

PRE-ACT leverages Artificial Intelligence (AI) to predict radiotherapy side effects in breast cancer patients, integrating complex imaging and genomics data. This Horizon Europe project aims to enhance shared decision-making by providing explainable predictions and tailored interventions, advancing personalised radiotherapy and improving patient outcomes.